FGF23 and chronic kidney disease: Additionally, a proteomics study also identified a multitude of mediators of inflammation (IL-6 and TNF-α) and mineral and bone disorders biomarkers (OPG, OPN, OCN, FGF23, and Fetuin-A) as a multiplexed panel to improve early CKD diagnosis.